The Long COVID-19 Wearable Device Study

ConditionsLong COVID Postural Orthostatic Tachycardia Syndrome Dysautonomia Myalgic Encephalomyelitis Chronic Fatigue Syndrome Long Covid19

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age18+

SponsorScripps Translational Science Institute

About this trial

To further characterize Long COVID-19 by collecting data from individuals who already own wearable devices or are provided with a wearable device along with basic and enhanced educational materials to determine if both can improve Long COVID-19 symptom management and post-exertional malaise.

Eligibility criteria

Qualifiers

Is at least 18 years old.

Long COVID (based on the WHO working definition),

ME/CFS (myalgic encephalomyelitis / chronic fatigue syndrome, self-diagnosis based on IOM criteria), and/or

POTS (Postural Orthostatic Tachycardia Syndrome).

Disqualifiers

As long as they meet inclusion there is no exclusion

Trial design

Treatments tested in this trial

Wearable device

Treatment groups

100,500 Participants

are divided into 4 treatment groups

Locations

Scripps Research92037, La JollaCalifornia, United States

Sponsors and collaborators

Scripps Translational Science Institute

Lead sponsor

Source ClinicalTrials.gov